![]() |
|
|



* Department of Biological Science, University of Tulsa, 600 S. College Avenue, Tulsa, OK 74104;
Department of Physiology and
** Department of Cellular and Structural Biology, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229; and
South Texas Veterans Health Care System at San Antonio, San Antonio, TX 78229
3To whom correspondence should be addressed. E-mail: eun-han{at}utulsa.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: gene expression food restriction GLUT4 transgenic mouse GeneChip array
Food restriction (FR)4 extends life span and retards many age-related cellular and molecular changes in laboratory rats (14). However, its underlying mechanisms are not fully understood (5). Changes in gene expression occur with age and can markedly affect the physiological status of an organism. Consequently, altered gene expression undoubtedly plays an important role in directing the anti-aging mechanisms of FR. Richardson (6) hypothesized that FR retarded the age-related decline in gene expression and showed (7) that FR altered the transcription of a specific gene. Our earlier study (8) revealed that FR partially reversed age-related changes in gene expression.
The effect of FR in lowering plasma glucose levels was demonstrated in mice, rats, and nonhuman primates of different ages using a variety of FR regimens (912). The consistency of this finding suggests that decreased plasma glucose may be mechanistically involved in the retardation of aging by FR. Such a role is suggested by current knowledge of both FR and aging: FR exerts protective effects on cellular homeostasis by enabling appropriate rates of glucose utilization to occur at lower circulating levels. Therefore we hypothesized that decreased plasma glucose is an important factor in the anti-aging action of FR. If this is the case, then lowering plasma glucose in the absence of restricted food intake would be expected to exert the same or related beneficial effects as FR and to similarly retard aging.
To test our hypothesis, we used GLUT4 transgenic (TG) mice. The GLUT4 TG mouse overexpresses the GLUT4 glucose transporter protein in skeletal muscle, cardiac muscle, and adipose tissue (13). The result of this tissue-delimited expression is lifelong reduction in the level of plasma glucose similar to that of non-TG (NTG) FR mice (
20% reduction). However, TG mice have the same food intake and body weight as NTG mice that consume food ad libitum (AL). Restricting the food intake of TG mice by 40% results in a further lowering of plasma glucose (about 25% below the 20% reduced glucose levels of GLUT4 TG mice). The combination of genetic and nutritional manipulation thus produces mice with 3 different levels of plasma glucose but with comparable body weight and food intake (3,14). We investigated whether the reduced plasma glucose altered the pattern of gene expression in TG mice similarly to that of the FR mice using Affymetrix oligonucleotide arrays.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Sentinel mice were tested monthly by a veterinary pathologist in Laboratory Animal Resources at the University of Texas Health Science Center at San Antonio. Every 6 mo, the presence of murine virus antibodies was monitored with serum samples from sentinel mice by BioReliance. All tests were negative. All procedures involving the use of mice were approved by the Institutional Animal Care and Use Committee of the University of Texas Health Science Center and the Subcommittee for Animal Studies at the Audie L. Murphy Memorial Veterans Hospital.
Tissue collection and RNA preparation. Livers from 18 each of TG AL, TG FR, NTG AL, and NTG FR 4- to 6-mo-old male mice were collected between 1000 and 1200 h. The tissues were quickly frozen in liquid nitrogen and stored at 80°C until RNA extraction. Total RNA was extracted from each liver as previously described (15).
Screening of mRNA by Affymetrix GeneChip arrays. A total of 18 mice per treatment group was used; however, RNAs from 3 mice were pooled together (the same amount of RNA from each mouse) to generate 6 pooled samples for each treatment group (i.e., NTG AL 16, NTG FR 16, TG AL 16, and TG FR 16, n = 6 arrays per treatment group).
Murine Genome U74A Version 2 GeneChips containing oligonucleotide probes for
12,000 genes were purchased from Affymetrix. We followed the vendors protocols for the GeneChip hybridization and scanning (16).
Statistical analysis of microarray data. Affymetrix Microarray Suite version 5.0 (MAS 5.0, Affymetrix) was used to quantitate each GeneChip (17). The summary intensities for each probe (24 CEL files) were loaded into DNA-Chip Analyzer (dChip), version 1.3 (18), for normalization, generation of expression measures, and analysis. For normalization, we used dChips method of invariant set normalization in which the chip with the median intensity value (TG FR 4) was used as the baseline against the remaining 23 chips. Model-based expression values were then calculated using dChips Perfect-Match-only model. Following dChips standards for defining array outliers (chips with >5% of probe sets flagged as array outliers), we removed 2 chips from further consideration, TG AL 3 (5.5%) and TG FR 3 (16.3%). The remaining 22 arrays were renormalized in dChip as above. For this subset, NTG FR 6 had the median intensity value and was used as the baseline against which the remaining 21 chips were normalized. Measurement expression values were again computed in dChip as above. In this set of samples, single outliers accounted for from 0.02 to 1.01% of genes (median = 0.26%) and were treated as missing values in subsequent analyses. These data (i.e., outlier arrays and single outlier values deleted) were log base 2 transformed and the analyses as detailed below were assayed on these values.
We analyzed 6 ANOVA-based group comparisons: 1) AL vs. FR, 2) NTG AL vs. NTG FR, 3) TG AL vs. TG FR, 4) NTG vs. TG, 5) NTG AL vs. TG AL, and 6) NTG FR vs. TG FR. In addition, we ran a SAS (statistical analysis system) mixed model with Scheffé adjustment for multiple comparisons to assess the presence of an interaction between genotype and diet. For the 6 group comparisons, rather than choosing a method for generating multiple comparison adjusted P values, we chose to use 3 statistical methods and focus on results in common to the 3 methods. As an additional "correction," we estimated the false discovery rate (FDR) within each method as a quality indication for the subset selection. Comparisons were conducted in dChip, in Significance Analysis of Microarrays (SAM) (19), and in SAS, version 8.02 for Windows/PCs. Our final results were composed of those genes found to differ significantly in all 3 methods of analysis at a P value of <0.001 or, in the case of SAM, at the minimum FDR, not to exceed 5%.
Real-time quantitative RT (QRT)-PCR. The same sources of RNA used for the GeneChip array study were used for the real-time QRT-PCR. Primers were designed using the OligoPerfect Designer (Invitrogen) and purchased from Invitrogen. Supplemental Table 1 includes the list of genes, their primer sequences, and the annealing temperatures. The 18S rRNA was used as an internal control for PCR quantitation. DNase I (Invitrogen) digestion, reverse transcription reaction with SuperScript II RT (Invitrogen), and PCR reaction using a Smart Cycler thermal cycler (Cepheid) were carried out as previously described (20). The specificity of the reaction is monitored by determining the product melting curve to avoid nonspecific signals.
Relative quantitation of gene expression was performed using the method published by Marino et al. (20). Briefly, using a Visual Basic Excel macro, the Smart Cycler optics data were converted to a logarithmic format, and then slopes, intercepts, and their respective standard errors for the samples in each experimental group were determined. If the slopes between 2 comparison groups are not different (P > 0.10), the amplification efficiency of a specific amplicon in these samples is comparable. Finally, fold changes and 95% confidence intervals were calculated.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
30% to 30-fold. Just as for the array hybridization, 6 samples per treatment group, each with RNA from the liver tissues of 3 mice, were used for the QRT-PCR. In Table 5, the array and the real-time QRT-PCR results are given as point estimates of the ratios of 2 comparison groups and the 95% confidence intervals are indicated in parentheses. Genes detected as significantly differentially expressed from 30% to 5-fold by FR using the array also showed similar changes in the real-time QRT-PCR measurements. Results confirmed that 16 of 21 array and QRT-PCR ratio pairs were equivalent, as indicated by the fact that their 95% confidence intervals overlapped. After 40 cycles of PCR, if desirable amplified gene products (melting peaks in the melt curves) were detected in samples of 1 treatment group and not detected in the other treatment group, we considered that gene to be turned off by the latter treatment or turned on by the former treatment. Real-time QRT-PCR results indicated 3 genes [FMO3; cyp, family 2, subfamily b, polypeptide 9 (cyp2B9); and cyp, family 2, subfamily b, polypeptide 13 (cyp2B13)] that have female specific expression in the liver (22,23) were expressed (turned on) in the liver tissues of our male FR mice and not expressed in the liver tissues of the male AL mice. One gene (HSD3b5) that is male specific in liver tissues (24) was not expressed (turned off) in FR samples (i.e., expressed in AL samples).
|
| DISCUSSION |
|---|
|
|
|---|
Three genes that are normally not expressed in the liver tissue of male mice were noted for being expressed by FR in this tissue: FMO3, cyp2B9, and cyp2B13. Flavin-containing monooxygenases are microsomal enzymes that catalyze the flavin adenine dinucleotide and NADPH- and O2-dependent oxidation of many nitrogen-, sulfur-, selenium-, and phosphorus-containing compounds (25). FMO3 expression was shown to be female specific in the mouse liver and this sex dependence appears to be due to repression of FMO3 expression by testosterone (26). Plasma testosterone is decreased by FR (27). Therefore, the reduced levels of testosterone may no longer repress FMO3 expression in male FR mice. The other 2 genes, cyp2B9 and cyp2B13, which were turned on by FR, are also female specific in the mouse liver (23). Since cyp2B9 is involved in testosterone metabolism (28), its induction may be partly responsible for the decreased testosterone in FR mice. We also found 1 gene that was turned off by FR. HSD3b5 belongs to the 3ß-hydroxysteroid dehydrogenase family (24). HDS3b5 is a NADPH-dependent 3-ketosteroid reductase and does not biosynthesize active steroid hormones, but rather converts an active androgen, dihydrotestosterone, into an inactive androgen, 5
-androgen-3ß,17ß-diol. The expression of HSD3b5 is specific in the male mouse liver, and Wong and Gill (28) reported that FR significantly suppressed HSD3b5 expression. Consistent with these findings, we observed that FR turned off the expression of HSD3b5 in the male mouse liver. Glucocorticoid downregulates HSD3b5 expression (28), and our early study indicated that FR is associated with an enhanced diurnal elevation of glucocorticoid (29). Thus, the increased plasma glucocorticoid by FR may suppress HSD3b5 expression in the male FR mouse liver.
Another noticeable observation from our current study was the regulation of cyp family genes by FR. Several genes from cyp family were either up- or downregulated by FR. Cyps act as monooxygenases, with functions ranging from the synthesis and degradation of endogenous steroid hormones, vitamins, and fatty acid derivatives to the metabolism of foreign compounds such as drugs, environmental pollutants, and carcinogens (30). Wong and Gill (28) reported that when mice were food restricted with corn oil at 60 to 70% of the amount normally eaten by control mice, the gene expression of cyp2B9 was upregulated while that of cyp7B1 was downregulated. Our data also indicated that cyp2B9 as well as cyp2B13, cyp2A4 and cyp2B10 were upregulated and that cyp7B1 as well as cyp4A12, cyp2D9, and cyp2F2 were downregulated by FR (supplemental Table 2).
When we grouped the genes by GO Chart categories, we noticed that FR altered the mRNA expression of many transcription factors. D site albumin promoter binding protein, RAB1, 2 nuclear receptor subfamilies (1D2 and 1H4), metal response element binding transcription factor 2, and thyrotroph embryonic factor were upregulated transcription factors by FR. RAB1 is a small GTP binding protein and is a key regulator of the intracellular vesicle transport (31). Nuclear receptor subfamily 1D2 is a possible clock-regulated gene (32). Metal response element binding transcription factor 2 may be involved in the activation of metallothionein genes in response to heavy-metal ions (33). Transcription factors downregulated by FR were interleukin 3 nuclear factor, interferon regulatory factor 6, and nuclear receptor subfamily 5A1. Interleukin 3 nuclear factor regulated the anti-apoptotic process (34). The differential expressions of the genes we detected could be the secondary effects of these altered transcription factor expressions as well as the primary effects of FR. We speculate that FR exerts its effect by altering the expression of transcription factors, which may give rise to the cascade effect to other genes. Other major biological processes influenced by FR were cell cycles, intracellular transport, carbohydrate metabolism, protein amino acid phosphorylation, and G proteincoupled receptor protein signaling pathway.
We compared genes we identified in our study with genes identified as differentially expressed by FR and/or aging from previously published gene expression array studies (3544) (Table 6). We found that 47 genes (the first 47 genes listed in Table 6) altered by FR in our study corresponded with results from previously published data. Of those 47, 7 genes (the 41st through the 47th listed in Table 6) showed age-related change in their expression and FR reversed the effect in previously published studies. The comparison also indicated that our study identified an additional 20 genes (the 48th through the 67th listed in Table 6) in which FR reversed age-related gene expression.
|
Whether the changes in gene expression that have been identified in this study represent changes in expression per se or changes in the distribution of cell types within the liver cannot be assessed by these studies. Also, we do not know whether these changes result in corresponding changes in protein expression/activity. Nevertheless, this study identified genes affected by short-term FR in young male mice. These findings are novel and likely to provide impetus to many investigators with expertise in the functions of the identified genes to pursue more mechanistic studies to understand the physiological significance of these changes in the anti-aging actions of FR.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supplemental files are available with the online posting of this paper at www.nutrition.org. ![]()
4 Abbreviations used: AL, consumed food ad libitum; cyp, cytochrome P450; cyp2B9, cytochrome P450, family 2, subfamily b, polypeptide 9; cyp2B13, cytochrome P450, family 2, subfamily b, polypeptide 13; cyp7B1, cytochrome P450, family 7, subfamily b, polypeptide 1; dChip, DNA-chip analyzer; FDR, false discovery rate; FMO3, flavin-containing monooxygenase 3; FR, food restriction; GO, gene ontology; HSD3b5, 3ß-hydroxysteroid dehydrogenase V; MAS, microarray suite; NTG, nontransgenic; PM, perfect match; QRT-PCR, quantitative RT-PCR; SAM, significance analysis of microarrays; SAS, statistical analysis system; TG, transgenic. ![]()
5 The proximate composition of Harlan Teklad LM-485 mouse/rat sterilizable diet 7912 is 19.92% protein, 5.67% fat, 4.37% fiber, 6.48% ash, 53.66% nitrogen-free extract, and 2.90% linoleic acid. ![]()
Manuscript received 6 May 2004. Initial review completed 28 June 2004. Revision accepted 3 August 2004.
| LITERATURE CITED |
|---|
|
|
|---|
1. Masoro, E. J. (1988) Food restriction in rodents: an evaluation of its role in the study of aging. J. Gerontol. 43:B59-B64.[Medline]
2. Masoro, E. J. (1990) Assessment of nutritional components in prolongation of life and health by diet. Proc. Soc. Exp. Biol. Med. 193:31-34.[Abstract]
3. Masoro, E. J. (1992) Retardation of aging processes by nutritional means. Ann. N.Y. Acad. Sci. 672:29-35.[Medline]
4. Weindruch, R. & Walford, R. L. (1988) The Retardation of Aging and Disease by Dietary Restriction 1988:436 Thomas Springfield, IL.
5. Masoro, E. J. & Austad, S. N. (1996) The evolution of the antiaging action of dietary restriction: a hypothesis. J. Gerontol. 51:B389-B391.
6. Richardson, A. (1985) The effect of age and nutrition on protein synthesis by cells and tissues from mammals. Watson, R. R. eds. Handbook of Nutrition and Aging 1985:31 CRC Press Boca Raton, FL. .
7. Richardson, A., Butler, J. A., Rutherford, M. S., Semsei, I., Gu, M. Z., Fernandes, G. & Cheung, W. H. (1987) Effect of age and dietary restriction on the expression of a2u-globulin. J. Biol. Chem. 262:12821-12825.
8. Han, E. S., Hilsenbeck, S. G., Richardson, A. & Nelson, J. F. (2000) cDNA expression arrays reveal incomplete reversal of age-related changes in gene expression by calorie restriction. Mech. Ageing Dev. 115:157-174.[Medline]
9. Masoro, E. J., McCarter, R. J., Katz, M. S. & McMahan, C. A. (1992) Dietary restriction alters characteristics of glucose fuel use. J. Gerontol. 47:B202-B208.[Medline]
10. Cefalu, W. T., Bell-Farrow, A. D., Wang, Z. Q., Sonntag, W. E., Fu, M. X., Baynes, J. W. & Thorpe, S. R. (1995) Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. J. Gerontol. 50:B337-B341.
11. Harris, S. B., Gunion, M. W., Rosenthal, M. J. & Walford, R. L. (1994) Serum glucose, glucose tolerance, corticosterone and free fatty acids during aging in energy restricted mice. Mech. Ageing Dev. 73:209-221.[Medline]
12. Kemnitz, J. W., Roecker, E. B., Weindruch, R., Elson, D. F., Baum, S. T. & Bergman, R. N. (1994) Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am. J. Physiol. 266:E540-E547.
13. Liu, M. L., Olson, A. L., Moye-Rowley, W. S., Buse, J. B., Bell, G. I. & Pessin, J. E. (1992) Expression and regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J. Biol. Chem. 267(17):11673-11676.
14. McCarter, R., Strong, R., Mejia, W., Goei, K. & Gibbs, M. (2002) Plasma glucose and body temperature as mediators of aging in calorie restriction. Biogerontology 3(Suppl. 1):11-12.
15. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY.
16. Han, E. S., Wu, Y., McCarter, R., Nelson, J. F., Richardson, A. & Hilsenbeck, S. G. (2004) Reproducibility, sources of variability, pooling, and sample size: important considerations for the design of high density oligonucleotide array experiments. J. Gerontol. Biol. Sci. 59A:306-315.
17. Affymetrix, Inc () [Online] (2004) Statistical Algorithms Description Document. http://www.affymetrix.com/support/technical/whitepapers/sadd_whitepaper.pdf [accessed Feb. 20, 2004].
18. Li, C. & Wong, W. H. (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U.S.A. 98:31-36.
19. Tusher, V., Tibshirani, R. & Chu, C. (2001) Significance analysis of microarrays applied to ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98:5116-5121.
20. Marino, J. H., Cook, P. & Miller, K. S. (2003) Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J. Immunol. Methods 283:291-306.[Medline]
21. Database for Annotation, Visualization, and Integrated Discovery (DAVID) () [Online] (2004) Gene Ontology Charts. http://david.niaid.nih.gov/David/ [accessed Feb. 20, 2004].
22. Falls, J. G., Cherrington, N. J., Clements, K. M., Rose, R. L., Levi, P. E. & Hodgson, E. (1997) Molecular cloning, sequencing, and expression in E. coli of murine flavin-containing monooxygenase 3 (FMO3). Arch. Biochem. Biophys. 34:9-18.
23. Lakso, M., Masaki, R., Noshiro, M. & Negishi, M. (1991) Structures and characterization of sex-specific mouse cytochrome P-450 genes as members within a large family: Duplication boundary and evolution. Eur. J. Biochem. 195:477-486.[Medline]
24. Wong, J. S., Ye, X., Muhlenkamp, C. R. & Grill, S. S. (2002) Effect of a peroxisome proliferators on 3ß-hydroxysteroid dehydrogenase. Biochem. Biophys. Res. Commun. 293:549-553.[Medline]
25. Ripp, S. L., Itagaki, K., Philpot, R. M. & Elfarra, A. A. (1999) Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metab. Dispos. 27:46-52.
26. Falls, J. G., Ryu, D. Y., Cao, Y., Levi, P. E. & Hodgson, E. (1997) Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch. Biochem. Biophys. 342:212-223.[Medline]
27. Young, K. A., Zirkin, B. R. & Nelson, R. J. (2000) Testicular regression in response to food restriction and short photoperiod in white-footed mice (Peromycus leucopus) is mediated by apoptosis. Biol. Reprod. 62:347-354.
28. Wong, J. S. & Gill, S. S. (2002) Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 185:180-196.[Medline]
29. Han, E. S., Evans, T. R. & Nelson, J. F. (1998) Adrenocortical responsiveness to adrenocorticotropic hormone is enhanced in chronically food restricted rats. J. Nutr. 128:1415-1420.
30. Honkakoski, P. & Negishi, M. (2000) Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347:321-337.[Medline]
31. Wedemeyer, N., Schmitt-John, T., Evers, D., Thiel, C., Eberhard, D. & Jockusch, H. (2000) Conservation of the 3'-untranslated region of the Rab 1a gene in amniote vertebrates: exceptional structure in marsupials and possible role for posttranscriptional regulation. FEBS Lett. 447:49-54.
32. Storch, K. F., Lipan, O., Leykin, I., Viswanathan, N., Davis, F. C., Wong, W. H. & Weitz, C. J. (2002) Extensive and divergent circadian gene expression in liver and heart. Nature 417:78-83.[Medline]
33. Inouye, C., Remondelli, P., Karin, M. & Elledge, S. (1994) Isolation of a cDNA encoding a metal response element binding protein using a novel expression cloning procedure: the one hybrid system. DNA Cell. Biol. 13:731-742.[Medline]
34. Ikushima, S., Inukai, T., Inaba, T., Nimer, S. D., Cleveland, J. L. & Look, A. T. (1997) Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 94:2609-2614.
35. Blalock, E. M., Chen, K. C., Sharrow, K., Herman, J. P., Porter, N. M., Foster, T. C. & Landfield, P. W. (2003) Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 23:3807-3819.
36. Cao, S. X., Dhahbi, J. M., Mote, P. L. & Spindler, S. R. (2001) Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc. Natl. Acad. Sci. U.S.A. 98:10630-10635.
37. Dhahbi, J. M., Kim, H.-J., Mote, P. L., Beaver, R. J. & Spindler, S. R. (2004) Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc. Natl. Acad. Sci. U.S.A. 101:5524-5529.
38. Edwards, M. G., Sarkar, D., Klopp, R., Morrow, J. D., Weindruch, R. & Prolla, T. A. (2003) Age-related impairment of the transcriptional responses to oxidative stress in the mouse heart. Physiol. Genom. 13:119-127.
39. Jiang, C. H., Tsien, J. Z., Schultz, P. G. & Hu, Y. (2001) The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. U.S.A. 98:1930-1934.
40. Kayo, T., Allison, D. B., Weindruch, R. & Prolla, T. A. (2001) Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc. Natl. Acad. Sci. U.S.A. 98:5093-5098.
41. Lee, C. K., Klopp, R. G., Weindruch, R. & Prolla, T. A. (1999) Gene expression profile of aging and its retardation by caloric restriction. Science 285:1390-1393.
42. Lee, C. K., Weindruch, R. & Prolla, T. A. (2000) Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:294-297.[Medline]
43. Lee, C. K., Allison, D. B., Brand, J., Weindruch, R. & Prolla, T. A. (2002) Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse heart. Proc. Natl. Acad. Sci. U.S.A. 99:14988-14993.
44. Tsuchiya, T., Dhahbi, J. M., Cui, X., Mote, P. L., Bartke, A. & Spindler, S. R. (2004) Additive regulation of hepatic gene expression by dwarfism and caloric restriction. Physiol. Genom. 17:307-315.
45. Liu, M. L., Gibbs, E. M., McCoid, S. C., Milici, A. J., Stukenbrok, H. A., McPherson, R. K., Treadway, J. L. & Pessin, J. E. (1993) Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. Proc. Natl. Acad. Sci. U.S.A. 90:11346-11350.
This article has been cited by other articles:
![]() |
J. M. Dhahbi, P. L. Mote, G. M. Fahy, and S. R. Spindler Identification of potential caloric restriction mimetics by microarray profiling Physiol Genomics, November 17, 2005; 23(3): 343 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-S. Han and M. Hickey Microarray Evaluation of Dietary Restriction J. Nutr., June 1, 2005; 135(6): 1343 - 1346. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||